Biotech | October 04, 2022
The integrated services ensure that NextPoint can bring their molecule to the clinic in a timely manner.
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The expansion makes Exothera one of the largest viral vector facilities in Europe
Subscribe To Our Newsletter & Stay Updated
